Product NDC: | 0039-0221 |
Proprietary Name: | AMARYL |
Non Proprietary Name: | glimepiride |
Active Ingredient(s): | 1 mg/1 & nbsp; glimepiride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0039-0221 |
Labeler Name: | Sanofi-Aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020496 |
Marketing Category: | NDA |
Start Marketing Date: | 20090618 |
Package NDC: | 0039-0221-10 |
Package Description: | 100 TABLET in 1 BOTTLE (0039-0221-10) |
NDC Code | 0039-0221-10 |
Proprietary Name | AMARYL |
Package Description | 100 TABLET in 1 BOTTLE (0039-0221-10) |
Product NDC | 0039-0221 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | glimepiride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090618 |
Marketing Category Name | NDA |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | GLIMEPIRIDE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |